Removing heavy metals,
promoting human health
A clinical-stage pharmaceutical company developing novel therapeutics designed to prevent and treat the toxic effects of heavy metal exposure on human health.
We are addressing the urgent need for better solutions to heavy metal toxicity. Our investigational, orally-administered chelating agents are being developed with the goal of simplifying treatment for patients exposed to radioactive materials like uranium and plutonium, as well as environmental toxins such as lead, mercury, and other heavy metals.
With a world-class team backed by over 20 years of funding from, and partnership with, the U.S. government, our research is advancing towards our vision of a future without heavy metal poisoning.
With a world-class team backed by over 20 years of funding from, and partnership with, the U.S. government, our research is advancing towards our vision of a future without heavy metal poisoning.
